RxDoctor Payments Data

Loubert Suddaby, MD

Neurological Surgery · Hamburg, NYNPI 1609869783

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $296,225 of the $322,973 with a category attached, or 91.7%. Stryker accounts for 85.3% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2021 at $74,400 and has fallen 72.9% since, to $20,161 in 2025. Among neurological surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$322,973in general payments, 2019–2025

Across 480 payments — averaging $672.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$276K
  • VB Spine LLC$13K
  • Kyocera Medical Technologies, Inc.$12K
  • Abbott$8K
  • Globus Medical$7K
  • Bacterin International Inc$3K
  • plus $3K from 13 others

What the payments were for

  • Royalty or licence$296,22592%
  • Consulting fees$12,4004%
  • Speaking & faculty fees$3,2751%
  • Travel & lodging$1,2880%
  • Food & beverage$9,7853%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$322,973 in reported general payments places this provider in the 95th percentile of 446 neurological surgery providers in New York.

See all neurological surgery providers in New York

Medicare billing

Part B allowed, 2024
$27,087
Medicare patients
55
Services billed
466

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium65$820
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$449
Cyclobenzaprine Hcl28$395
Gabapentin31$390
Ibuprofen24$279
Dexamethasone28$168
Tramadol Hcl46$124
Methylprednisolone11$87
Famotidine21$84

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Hamburg

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →